Bevacizumab for the treatment of a complicated posterior melanocytoma

Julio A Urrets-Zavalia,* Nicolas Crim,* Evangelina Esposito, Leandro Correa, M Eugenia Gonzalez-Castellanos, Dana MartinezDepartment of Ophthalmology, University Clinic Reina Fabiola, Universidad Catolica de Cordoba, Cordoba, Argentina*These authors contributed equally to this workPurpose:...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Urrets-Zavalia JA, Crim N, Esposito E, Correa L, Gonzalez-Castellanos ME, Martinez D
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/cdf3b33e2695472e85f60f0f1f50797b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cdf3b33e2695472e85f60f0f1f50797b
record_format	dspace
spelling	oai:doaj.org-article:cdf3b33e2695472e85f60f0f1f50797b2021-12-02T02:41:56ZBevacizumab for the treatment of a complicated posterior melanocytoma1177-5483https://doaj.org/article/cdf3b33e2695472e85f60f0f1f50797b2015-03-01T00:00:00Zhttp://www.dovepress.com/bevacizumab-for-the-treatment-of-a-complicated-posterior-melanocytoma-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483 Julio A Urrets-Zavalia,* Nicolas Crim,* Evangelina Esposito, Leandro Correa, M Eugenia Gonzalez-Castellanos, Dana MartinezDepartment of Ophthalmology, University Clinic Reina Fabiola, Universidad Catolica de Cordoba, Cordoba, Argentina*These authors contributed equally to this workPurpose: To present a case of a complicated posterior melanocytoma that was successfully treated with intravitreal bevacizumab.Case report: A 50-year-old Caucasian man was referred with sudden-onset metamorphopsia and decreased vision in his right eye over the course of the last 2 months. His best-corrected visual acuity was 20/80 and poorer than Jaeger 14 in the right eye, and 20/20 and Jaeger 1 in his left eye. In the right fundus, there was a melanocytic lesion occupying the inferotemporal quadrant of the optic disk, extending to the adjacent choroid inferiorly; optic nerve edema, superotemporal retinal vein dilatation, and subretinal fluid under the macula and nasal half of the posterior pole were observed, and a subretinal choroidal neovascularization complex was observed adjacent to the superotemporal margin of the optic disk, confirmed by fluorescein angiography, surrounded by a dense subretinal hemorrhage. Optical coherence tomography showed retinal edema and detachment of neurosensory retina. The patient was treated with three consecutive doses on a monthly basis of intravitreal 1.25 mg/0.05 mL bevacizumab. Visual acuity recovered rapidly, and at 4 months after treatment, it was 20/20 and Jaeger 1, with complete resolution of macular edema and subretinal fluid and hemorrhage. After 3 years of follow-up, best-corrected visual acuity remained stable, macular area was normal, and there was no evident optic nerve edema, retinal vein caliber and aspect were normal, and there was no significant change of the tumor. Fluorescein angiography only evidenced late staining of choroidal neovascularization scar, and optical coherence tomography showed a normal macular anatomy.Conclusion: Intravitreal bevacizumab was effective in the treatment of choroidal neovascularization, optic nerve edema, venous dilatation, and local capillary telangiectasia, complicating an optic disk melanocytoma.Keywords: optic disk melanocytoma, choroidal neovascularization, bevacizumab, retinal telangiectasiaUrrets-Zavalia JACrim NEsposito ECorrea LGonzalez-Castellanos MEMartinez DDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2015, Iss default, Pp 455-459 (2015)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Urrets-Zavalia JA Crim N Esposito E Correa L Gonzalez-Castellanos ME Martinez D Bevacizumab for the treatment of a complicated posterior melanocytoma
description	Julio A Urrets-Zavalia,* Nicolas Crim,* Evangelina Esposito, Leandro Correa, M Eugenia Gonzalez-Castellanos, Dana MartinezDepartment of Ophthalmology, University Clinic Reina Fabiola, Universidad Catolica de Cordoba, Cordoba, Argentina*These authors contributed equally to this workPurpose: To present a case of a complicated posterior melanocytoma that was successfully treated with intravitreal bevacizumab.Case report: A 50-year-old Caucasian man was referred with sudden-onset metamorphopsia and decreased vision in his right eye over the course of the last 2 months. His best-corrected visual acuity was 20/80 and poorer than Jaeger 14 in the right eye, and 20/20 and Jaeger 1 in his left eye. In the right fundus, there was a melanocytic lesion occupying the inferotemporal quadrant of the optic disk, extending to the adjacent choroid inferiorly; optic nerve edema, superotemporal retinal vein dilatation, and subretinal fluid under the macula and nasal half of the posterior pole were observed, and a subretinal choroidal neovascularization complex was observed adjacent to the superotemporal margin of the optic disk, confirmed by fluorescein angiography, surrounded by a dense subretinal hemorrhage. Optical coherence tomography showed retinal edema and detachment of neurosensory retina. The patient was treated with three consecutive doses on a monthly basis of intravitreal 1.25 mg/0.05 mL bevacizumab. Visual acuity recovered rapidly, and at 4 months after treatment, it was 20/20 and Jaeger 1, with complete resolution of macular edema and subretinal fluid and hemorrhage. After 3 years of follow-up, best-corrected visual acuity remained stable, macular area was normal, and there was no evident optic nerve edema, retinal vein caliber and aspect were normal, and there was no significant change of the tumor. Fluorescein angiography only evidenced late staining of choroidal neovascularization scar, and optical coherence tomography showed a normal macular anatomy.Conclusion: Intravitreal bevacizumab was effective in the treatment of choroidal neovascularization, optic nerve edema, venous dilatation, and local capillary telangiectasia, complicating an optic disk melanocytoma.Keywords: optic disk melanocytoma, choroidal neovascularization, bevacizumab, retinal telangiectasia
format	article
author	Urrets-Zavalia JA Crim N Esposito E Correa L Gonzalez-Castellanos ME Martinez D
author_facet	Urrets-Zavalia JA Crim N Esposito E Correa L Gonzalez-Castellanos ME Martinez D
author_sort	Urrets-Zavalia JA
title	Bevacizumab for the treatment of a complicated posterior melanocytoma
title_short	Bevacizumab for the treatment of a complicated posterior melanocytoma
title_full	Bevacizumab for the treatment of a complicated posterior melanocytoma
title_fullStr	Bevacizumab for the treatment of a complicated posterior melanocytoma
title_full_unstemmed	Bevacizumab for the treatment of a complicated posterior melanocytoma
title_sort	bevacizumab for the treatment of a complicated posterior melanocytoma
publisher	Dove Medical Press
publishDate	2015
url	https://doaj.org/article/cdf3b33e2695472e85f60f0f1f50797b
work_keys_str_mv	AT urretszavaliaja bevacizumabforthetreatmentofacomplicatedposteriormelanocytoma AT crimn bevacizumabforthetreatmentofacomplicatedposteriormelanocytoma AT espositoe bevacizumabforthetreatmentofacomplicatedposteriormelanocytoma AT correal bevacizumabforthetreatmentofacomplicatedposteriormelanocytoma AT gonzalezcastellanosme bevacizumabforthetreatmentofacomplicatedposteriormelanocytoma AT martinezd bevacizumabforthetreatmentofacomplicatedposteriormelanocytoma
_version_	1718402250813997056

Bevacizumab for the treatment of a complicated posterior melanocytoma

Ejemplares similares